Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy in Patients With Moderate-Severe Renal Dysfunction

NCT05909059 is registered in ClinicalTrials.gov with Northside Hospital, Inc. as lead sponsor.

NCT NCT05909059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05909059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lymphodepleting Chemotherapy With Fludarabine and Cyclophosphamide Prior to Infusion of CAR T Cell Therapy in Patients With Moderate-Severe Renal Dysfunction
Lead sponsor
Northside Hospital, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
November 18, 2024
Completion date
August 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, adult, multiple myeloma, non-hodgkin lymphoma,b cell